Honey Consumption, Oxidative Stress and Health

May 27, 2023 updated by: Athanasios Z. Jamurtas, University of Thessaly

The Effect of a Honey-based Gel Supplement From the Wider Area of Pindos on Human Health and Oxidative Stress Biomarkers

The aim of the present clinical study is to estimate the efficacy of a honey-based gel, derived from the wider area of Pindos in Greece, in regulating oxidative stress biomarkers and the physiological profile of healthy adults.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Introduction: Honey contains about 200 compounds such as sugars, proteins, vitamins, water, free amino acids, enzymes, minerals, and many phytochemicals. Due to its composition, enriched with many bioactive ingredients, several studies have established its antimicrobial, antiviral, anticancer, antidiabetic and antioxidant properties. This multilayer activity of honey has been proposed for the protection against pathologies interrelated with the cardiovascular, nervous, respiratory, and gastrointestinal system.

Purpose: This study aims to investigate the effects of a novel natural honey-based gel consumption on oxidative stress biomarkers, blood chemistry and physiological characteristics in healthy individuals.

Methodology: A total of 20 healthy men and women will participate in the study. Participants will give their informed consent after they will be informed about the purposes, procedures, risks and benefits associated with the study. Participants will consume 70 g/day of the honey-based gel, distributed in 2 equal doses (in the morning and evening) for 14 days. At baseline and post-intervention, volunteers will be assessed for their physiological profile and will provide a resting blood sample for the assessment of oxidative stress and blood chemistry biomarkers as well as their physiological profile. Participants will be asked to record their diet for 3 days prior to the study and they will be asked to follow the same dietary pattern for 3 days before the post-intervention assessments.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thessaly
      • Trikala, Thessaly, Greece, 42150
        • Exercise Biochemistry, Physiology and Nutrition Laboratory, Department of Physical Education and Sport Science, University of Thessaly

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy Individuals aged 18-65 years
  • Non-smokers

Exclusion Criteria:

  • Musculoskeletal injury
  • Dietary supplements
  • Medication
  • Allergy in bee pollen

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Honey-based gel consumption
A honey-based gel will be administered to participants in this arm.
70 g/day of a honey-based gel divided into 2 equal doses of 35 gr (in the morning and evening) for a total duration of 14 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in glutathione concentration of erythrocytes
Time Frame: Change from baseline to 14 days
Glutathione concentration will be analyzed in erythrocytes by spectrophotometry
Change from baseline to 14 days
Change in catalase enzyme activity of erythrocytes
Time Frame: Change from baseline to 14 days
Catalase enzyme activity will be analyzed in erythrocytes by spectrophotometry
Change from baseline to 14 days
Change in total antioxidant capacity of plasma
Time Frame: Change from baseline to 14 days
Total antioxidant capacity will be analyzed in plasma by spectrophotometry
Change from baseline to 14 days
Change in thiobarbituric acid reactive substances of plasma
Time Frame: Change from baseline to 14 days
Thiobarbituric acid reactive substances will be analyzed in plasma by spectrophotometry
Change from baseline to 14 days
Change in protein carbonyls of plasma
Time Frame: Change from baseline to 14 days
Protein Carbonyls will be analyzed in plasma by spectrophotometry
Change from baseline to 14 days
Change in body weight
Time Frame: Change from baseline to 14 days
Body weight will be measured using a digital scale
Change from baseline to 14 days
Change in body fat
Time Frame: Change from baseline to 14 days
Body fat will be measured by bioelectrical impedance analysis
Change from baseline to 14 days
Change in resting heart rate
Time Frame: Change from baseline to 14 days
Resting heart rate will be measured using a heart rate sensor
Change from baseline to 14 days
Change in diastolic and systolic blood pressure
Time Frame: Change from baseline to 14 days
Diastolic and systolic blood pressure will be measured using a manual sphygmomanometer
Change from baseline to 14 days
Change in waist and hip circumference
Time Frame: Change from baseline to 14 days
Waist and hip circumference will be assessed using a tape measure
Change from baseline to 14 days
Change in complete blood count
Time Frame: Change from baseline to 14 days
White blood cells, lymphocytes, monocytes, granulocytes, red blood cells and platelets will be analyzed in whole blood
Change from baseline to 14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Athanasios Z. Jamurtas, Professor, University of Thessaly

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2023

Primary Completion (Actual)

May 25, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

February 18, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 6, 2023

Study Record Updates

Last Update Posted (Actual)

May 31, 2023

Last Update Submitted That Met QC Criteria

May 27, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • UTH-HoneyGel

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oxidative Stress

Clinical Trials on Honey-based gel supplementation

Subscribe